Sunshine Biopharma Inc. Accumulated Other Comprehensive Income
Sunshine Biopharma Inc. (SBFM) had Accumulated Other Comprehensive Income of -$658.93 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$658.93K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$343.31K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$65.31K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$320.84K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$658.93K 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$343.31K 10-Q · filed 2026-05-13 |
| 2025-12-31 | -$65.31K 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$320.84K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $280.79K 10-Q · filed 2025-08-12 |
| 2025-03-31 | -$803.77K 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$829.96K 10-K · filed 2026-04-03 |
| 2024-09-30 | $168.59K 10-Q · filed 2024-11-05 |
| 2024-06-30 | -$683.05K 10-Q/A · filed 2024-08-20 |
| 2024-03-31 | $152.40K 10-Q · filed 2024-05-20 |
| 2023-12-31 | $696.11K 10-K · filed 2025-04-01 |
| 2023-09-30 | $204.55K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $665.06K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $173.01K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $161.85K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$79.90K 10-Q · filed 2022-11-07 |
| 2022-06-30 | -$34.78K 10-Q · filed 2022-08-03 |
| 2022-03-31 | -$22.13K 10-Q · filed 2022-05-06 |
| 2021-12-31 | -$23.14K 10-K · filed 2023-04-04 |
| 2021-09-30 | -$17.48K 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$11.64K 10-Q · filed 2021-08-09 |
| 2021-03-31 | -$4.93K 10-Q · filed 2021-05-11 |
| 2020-12-31 | -$2.87K 10-K · filed 2022-03-21 |
| 2020-09-30 | -$3.50K 10-Q · filed 2020-11-12 |
| 2020-06-30 | -$3.36K 10-Q/A · filed 2020-08-31 |
| 2020-03-31 | -$3.84K 10-Q · filed 2020-05-18 |
| 2019-12-31 | -$2.50K 10-K · filed 2021-03-30 |
| 2019-09-30 | -$2.14K 10-Q · filed 2019-11-13 |
| 2019-06-30 | -$2.02K 10-Q · filed 2019-08-15 |
| 2019-03-31 | -$4.52K 10-Q · filed 2019-05-20 |
| 2018-12-31 | -$3.74K 10-K · filed 2020-05-01 |
| 2018-09-30 | $3.74K 10-Q · filed 2018-11-16 |
| 2018-06-30 | -$8.27K 10-Q · filed 2018-08-17 |
| 2018-03-31 | -$2.23K 10-Q · filed 2018-05-22 |
| 2017-12-31 | $504.00 10-K · filed 2019-04-12 |
| 2017-09-30 | $8.52K 10-Q · filed 2017-11-15 |
| 2017-06-30 | $4.19K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $1.90K 10-Q · filed 2017-05-12 |
| 2016-12-31 | $394.00 10-K · filed 2018-04-02 |
| 2016-09-30 | $1.77K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $2.07K 10-Q · filed 2016-08-16 |
| 2016-03-31 | -$9.25K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $740.00 10-K · filed 2017-04-17 |
| 2015-09-30 | $1.12K 10-Q · filed 2015-11-04 |
| 2015-06-30 | $4.36K 10-Q · filed 2015-08-06 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-25 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-12 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-12 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-11 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-19 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-08 |
| 2011-12-31 | $0.00 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |